VALIANT LABORATORIES
Back to Income Statement
|
VALIANT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Sales | ₹237 Cr | ₹133 Cr | ₹182 Cr | ₹334 Cr |
What is the latest Revenue of VALIANT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹237 Cr |
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹182 Cr |
| Mar2023 | ₹334 Cr |
How is Revenue of VALIANT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹237 Cr | 78.04 | |
| Mar2025 | ₹133 Cr | -26.74 | |
| Mar2024 | ₹182 Cr | -45.48 | |
| Mar2023 | ₹334 Cr | - | |
Compare Revenue of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹657.3 Cr | -5.6% | -3.6% | 50.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -5.6% |
-3.6% |
50.1% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses